Ultragenyx Pharmaceutical Inc header image

Ultragenyx Pharmaceutical Inc

RARE

Equity

ISIN null / Valor 22860122

NASDAQ (2026-09-25)

USD 14.50-1.83%

Ultragenyx Pharmaceutical Inc
UMushroom community rating:

3.17 12 votes No rating yet

NegativeNeutralPositive

About company

Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for rare and ultra-rare genetic diseases. The company's portfolio includes products such as DOJOLVI® for long-chain fatty acid oxidation disorders and CRYSVITA® for X-linked hypophosphatemia and tumor-induced osteomalacia. Ultragenyx is dedicated to providing patients with life-changing therapies that address unmet medical needs in the rare disease community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-47.9%1Y

-60.5%3Y

-84.8%5Y

Performance

75.8%1Y

59.9%3Y

57.1%5Y

Volatility

1430 M

Market cap (USD)

4,306,057

Daily traded volume (Shares)

43.045 / 41.53

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.17

12 votes

Performance:

3.50

Innovation:

3.50

Society:

3.42

Nature:

3.17

Hazem Baderon

Malaysia, 20 May 2026

Still consolidating, might be ok for long term

Han Yee Kong

Malaysia, 29 Apr 2026

.

oliver baigel

UK, 09 Nov 2025

a very low performing stock with a high level of risk

EQUITIES OF THE SAME SECTOR

Abbott Laboratories

Abbott Laboratories Valor: 903037

Annual Return

-50%0%+50%

Risk level

110

0.22%USD 101.29

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.85%CHF 360.30

Straumann Holding Ltd

Straumann Holding Ltd Valor: 117544866

Annual Return

-50%0%+50%

Risk level

110

1.14%CHF 97.48

BACHEM HOLDING LTD

BACHEM HOLDING LTD Valor: 117649372

Annual Return

-50%0%+50%

Risk level

110

-2.11%CHF 81.30

Faes Farma SA

Faes Farma SA Valor: 2837976

Annual Return

-50%0%+50%

Risk level

110

0.75%EUR 4.69

Tempus AI Inc

Tempus AI Inc Valor: 135855934

Annual Return

-50%0%+50%

Risk level

110

3.37%USD 85.01

QuidelOrtho Corporation

QuidelOrtho Corporation Valor: 119356965

Annual Return

-50%0%+50%

Risk level

110

2.34%USD 10.94

Revolution Medicines Inc

Revolution Medicines Inc Valor: 52143299

Annual Return

-50%0%+50%

Risk level

110

2.56%USD 204.97

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co Valor: 914188

Annual Return

-50%0%+50%

Risk level

110

2.21%USD 62.86

Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc Valor: 25419823

Annual Return

-50%0%+50%

Risk level

110

-2.94%USD 36.94

SIX

FactSet

Clearbit

Logos provided by Clearbit